Thrimoorthy Potta Email Address

Vice President, Research and Development

Insys Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing and commercializing products to address chemotherapy-induced nausea and vomiting (CINV) pain management and other central nervous system disorders. The Companys initial product candidate is a dronabinol hard gelatin (Dronabinol HG) capsule. It has filed an abbreviated new drug application (ANDA) for its Dronabinol HG capsule. Its other most advanced product candidates focus on its formulations and delivery methods for dronabinol, the active ingredient in Marinol, and fentanyl, the active ingredient in the pain management drugs Actiq and Fentora. Its internal development pipeline also includes fentanyl and dronabinol line extensions, and other pain management and central nervous system product candidates.

Over 10 years of experience in liquid/Solid dosage forms development, process development and process optimization. Successfully developed four sublingual spray products Experience with IND/NDA/505b(2) filings Experience in writing CMC section for regulatory submission In-depth knowledge of FDA guidance, cGMP and DEA compliance Sincere and dedicated team leader. Scientific Research publications 18+ U.S Patents 3